Выпуск
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
JAMA Neurology Author Interviews · 5 мая 2025 г. · 21 мин
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder